HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

7- (4- (diethylamino)butoxy)- 5- hydroxy- 3- (4- hydroxyphenyl)- 4H- chromen- 4- one

has estrogenic activity; structure in first source

Also Known As:

GS-14

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        Isoflavones: 2663
        Genistein: 2869
        7-(4-(diethylamino)butoxy)-5-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        Isoflavones: 2663
        Genistein: 2869
        7-(4-(diethylamino)butoxy)-5-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one: 1

Experts

1.	Jiang, Chun-Ping: 1 article (09/2012)
2.	Shi, Da-Hua: 1 article (09/2012)
3.	Wang, Yu-Rong: 1 article (09/2012)
4.	Wu, Jun-Hua: 1 article (09/2012)
5.	Yan, Zhi-Qiang: 1 article (09/2012)
6.	Zhang, Li-Na: 1 article (09/2012)

Related Diseases

1.

Alzheimer Disease (Alzheimer's Disease)

09/01/2012 - "To find the multi-target-directed compounds for the treatment of Alzheimer's disease (AD), we synthesized 7-(4-(diethylamino)butoxy)-5-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one, a novel 7-O-modified genistein derivative (GS-14), and investigated its acetylcholinesterase (AChE) inhibitory effect, estrogenic activity and neuroprotective effect. "

Related Drugs and Biologics

1.	Genistein
2.	Neuroprotective Agents
3.	Acetylcholinesterase